At this time, the Company has not received any reports of adverse events related to this recall. Bionpharma, Inc. is recalling 1 lot of Atovaquone Oral Suspension, USP 750mg/5mL due to microbial ...

[Elliot] put together an intriguing proof-of-concept script that uses repeated deauthentication packet bursts to jam WiFi access points. From what we can tell it’s a new way to use an old tool.

September 17, 2024 – Princeton, NJ, Bionpharma Inc. is voluntarily recalling (1) single Batch (2310083) of Atovaquone Oral Suspension, 750mg per mL to the consumer level.

The FDA-posted recall notice from Bionpharma said batch No. 2310083 of Atovaquone Oral Suspension, 750 mg, NDC No. 69452-252-87, was “found to be contaminated with Cohnella bacteria.” ...

A digital network technology that breaks up a message into smaller chunks (packets) for transmission. Unlike circuit switching in traditional telephone networks, which requires the establishment ...

Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). Proguanil, also known as chlorguanide and chloroguanide, is a medication used to treat and ...